ImmunoGen Announces Webcasts of Presentations at Upcoming Virtual Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:
  • Piper Sandler 32nd Annual Virtual Healthcare Conference
    November 23 at 10:00am ET
  • Evercore ISI Annual HealthCONx Conference
    December 1 at 12:10pm ET

A webcast of each presentation will be accessible through the Investors and Media section of the Company's website, Following the live webcast, a replay will be available at the same location.

More on Boston Chron

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to "target a better now."

Learn more about who we are, what we do, and how we do it at
Filed Under: Business

Show All News | Report Violation


Latest on Boston Chron